Cargando…
Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer
Background: Trimodality bladder preservation therapy (BPT) in muscle invasive bladder cancer (MIBC) includes a maximal transurethral resection followed by concurrent chemoradiotherapy as an alternative to radical cystectomy (RC) in appropriately selected patients, or as a treatment option in non-cys...
Autores principales: | Rose, Tracy L., Deal, Allison M., Ladoire, Sylvain, Créhange, Gilles, Galsky, Matthew D., Rosenberg, Jonathan E., Bellmunt, Joaquim, Wimalasingham, Akhila, Wong, Yu-Ning, Harshman, Lauren C., Chowdhury, Simon, Niegisch, Guenter, Liontos, Michalis, Yu, Evan Y., Pal, Sumanta K., Chen, Ronald C., Wang, Andrew Z., Nielsen, Matthew E., Smith, Angela B., Milowsky, Matthew I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5181658/ https://www.ncbi.nlm.nih.gov/pubmed/28035321 http://dx.doi.org/10.3233/BLC-160072 |
Ejemplares similares
-
Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database
por: Del Bene, Gabriella, et al.
Publicado: (2018) -
Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival
por: Ramos, Jorge D., et al.
Publicado: (2016) -
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
por: Kamat, Ashish M., et al.
Publicado: (2017) -
Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
por: Kamat, Ashish M., et al.
Publicado: (2017) -
New and Emerging Therapies in the Management of Bladder Cancer
por: Osterman, Chelsea K., et al.
Publicado: (2020)